On 27 April 2026, demonstrators gathered outside the US Supreme Court in Washington, DC, to voice their concerns about the safety of glyphosate, a key ingredient in the widely used herbicide Roundup. The case, Monsanto v Durnell, has ignited a fierce debate regarding pesticide regulation and consumer rights, as the court considers whether federal law protects the former Monsanto Company from state lawsuits alleging that its products cause cancer.
The Legal Battle Over Glyphosate
At the heart of this case is glyphosate, a chemical linked to cancer in numerous studies and classified as a probable human carcinogen by the World Health Organization in 2015. The former Monsanto, now owned by Bayer, has faced over 100,000 lawsuits from individuals who developed non-Hodgkin lymphoma and attribute their illness to glyphosate exposure. Bayer has already paid out billions in settlements and jury awards, yet it continues to assert that its products are safe.
During the recent court proceedings, justices interrogated lawyers representing Bayer, focusing on whether federal law under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-level lawsuits. Bayer’s legal counsel, Paul Clement, argued that the law prohibits pesticide manufacturers from altering safety warnings on labels without approval from the Environmental Protection Agency (EPA). He maintained that if the EPA has not mandated a cancer warning, then the company cannot be held liable.
The Controversy Surrounding EPA Regulations
Clement’s assertions were met with significant pushback from attorney Ashley Keller, who represented the plaintiffs in the case. Keller contended that FIFRA does not grant the sweeping protections claimed by Bayer and highlighted flaws in the EPA’s approval process, which he argued has failed to keep pace with new scientific findings. He pointed out that the Ninth Circuit Court of Appeals had previously vacated the EPA’s findings regarding glyphosate, citing inadequate adherence to established cancer risk evaluation guidelines.
As the attorneys presented their cases, the justices engaged in a rigorous exchange of questions. Some sought clarification on how to address new scientific evidence that may emerge between EPA reviews, while others expressed concern over the implications of allowing Bayer to escape liability for its product’s risks.
Activist Voices Rally for Change
Outside the Supreme Court, a coalition of activists, including members of the Maha movement and concerned citizens, rallied to demand accountability from chemical manufacturers like Bayer. Protesters chanted slogans such as “people over poison” and held signs reading “Roundup the guilty” and “Make Monsanto pay.” Zen Honeycutt, founder of Moms Across America, spoke passionately about the need for systemic change, urging the government to prioritise public health over corporate interests.
Prominent figures joined the protest, including Democratic Representative Chellie Pingree of Maine, who expressed gratitude for the outpouring of support from constituents across the political spectrum. Pingree, along with Republican Representative Thomas Massie, recently introduced an amendment to the new Farm Bill aimed at stripping chemical manufacturers of protections that would shield them from lawsuits related to dangerous products.
A Shifting Political Landscape
The Supreme Court’s ruling, expected this summer, could have far-reaching implications not only for Bayer and its glyphosate products but also for the broader pesticide industry. If the court sides with Monsanto, it could significantly hinder consumers’ ability to seek redress for damages associated with harmful chemicals.
The case unfolds at a time of increasing scrutiny on chemical safety and environmental regulations. As lawmakers debate the Farm Bill, the spotlight remains on the balance between agricultural needs and public health concerns.
Why it Matters
The outcome of this case is crucial, as it will shape the landscape of consumer rights and corporate accountability. With growing evidence linking glyphosate to serious health risks, the court’s decision could either uphold the status quo, allowing companies to evade responsibility, or pave the way for safer agricultural practices and stronger regulations. As the nation grapples with the implications of chemical exposure, the voices of concerned citizens and activists are more vital than ever in advocating for a healthier, more transparent future.
